Toggle navigation
Home
About
Funding
Location
Structure
Contact
Useful Links
Events
Press
Scientific Interest Groups
Clinical SIGs
Autoimmunity
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications of Interest
Mailing List
Radio Therapy
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications of Interest
Mailing List
Cystic fibrosis
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Clinical challenges
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Transplant - MATCH
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Imaging
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Core Function Groups
Bioinformatics
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Biobank
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications of Interest
Mailing List
Data Management
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Immunology Colloquiums
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Statistics
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications of Interest
Mailing List
Neutropenia/lymphopenia
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications of Interest
Mailing List
Microbiome Research
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications
Contact
Microbial Diagnostics
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Immunology
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publication of Interest
Mailing List
Publications
Presentations
Newsletters
CHIP
How to get involved
PERSIMUNE proposal approval principles
Scientific Advisory Committee
Data Cleaning
RH-departments involved
PERSIMUNE Data warehouse search
PERSIMUNE data sources
PERSIMUNE Documents
PERSIMUNE biobank documents
PERSIMUNE research documents
archive
Scientific Interest Groups
Core Function Groups
Neutropenia/lymphopenia
Members
Lead
Members
Description, goal and main tasks
Schedule of SIG meetings and agendas
Publications of Interest
Mailing List
Neutropenia/Lymphopenia
The neutropenia/lymphopenia SIG focus on elucidating risk factors for- and outcomes of neutropenia and lymphopenia among patients treated with chemotherapy and/or radiotherapy for malignant disease.
Neutropenia is a frequent and sometimes fatal complication of chemotherapy. Close monitoring and prophylactic treatment can reduce mortality, but is also associated with inconvenience, risk of toxicity, infections with resistant microorganisms and increased costs.
Radiotherapy can lead to severe and long-standing lymphopenia, but the risk factors for lymphopenia and its complications are not well elucidated.
Although patients receive the same type of therapy, only some develop neutropenia or lymphopenia and only some of those develop infectious complications. The reasons for this variation in risk is poorly understood.
With routine methods an infectious pathogen can only be detected in a minority of patients who develop febrile neutropenia after chemotherapy and most patients receive empiric broad spectrum antibiotics.
Therapy individualized according to risk stratification and novel diagnostic methods may improve patient outcomes.
Privacy Policy
|
Persondatapolitik for Region Hovedstaden
|
Personal data policy
|
| Sitemap
Login
This site uses cookies
We use cookies to analyze our traffic and provide a better user experience. You give your consent by clicking on the OK button or choose to continue.
Read more about our privacy and cookie policy